Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02569853 · ClinicalTrials.gov registry record · Phase 3
DFN-11 Injection in Episodic Migraine With or Without Aura
A Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
NCT02569853 is a Phase 3 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 268 participants.
The verdict
NCT02569853, a Phase 3 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
Study Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Interventions
- OTHER Placebo
- DRUG DFN-11
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2015-09-21 |
| Est. Completion | 2018-02-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02569853
The ClinicalTrials.gov registry entry for NCT02569853 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02569853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02569853 about?
NCT02569853 is a clinical study titled "DFN-11 Injection in Episodic Migraine With or Without Aura". Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
What is the current status of trial NCT02569853?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 2015-09-21. Estimated completion is 2018-02-26.
What interventions are being tested in trial NCT02569853?
The interventions under investigation include: Placebo (OTHER), DFN-11 (DRUG).
Who is sponsoring clinical trial NCT02569853?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.